BPA Call W81XWH22A0005-HT942726FE010
- Not listed
- The Defense Health Agency awarded a $22,910 firm fixed-price task order to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on March 13, 2024, for reagents required for casework analysis. This award represents a delivery order under the Defense Health Agency's $5.3 million Blanket Purchase Agreement with Biodiscovery, which is set to expire September 27, 2027. The BPA provides DHA with access to Biodiscovery's specialized genomic products, including custom DNA reagents, MYBAITS...
- The Defense Health Agency awarded a firm fixed-price delivery order valued at $27,470 to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on March 4, 2024, for MYBAITS human whole genome enrichment reagents, specifically 96 reaction quantity 2 and associated reagents. This contract award was issued as a call under an existing Blanket Purchase Agreement and does not utilize a small business set-aside designation. The work will be performed at the contractor's facility in Ann Arbor,...
- The Defense Health Agency awarded a firm fixed-price BPA call valued at $414,352 to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on June 13, 2023, for the delivery of MYBAITS-1-768-B DNA MYBAITS 1-768-B reagents (quantity 7). This contract award represents a task order under the agency's $5.3 million blanket purchase agreement with Biodiscovery for custom DNA and MYBAITS reagents, which runs through September 27, 2027. No small business set-aside designation was used for this...
- The Defense Health Agency awarded a $368,160 firm-fixed-price BPA call to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on July 11, 2024, for the delivery of custom MYBAITS reagents in quantities of 160,000 to 180,000 units. The contract, which carries an ultimate completion date of July 26, 2024, is not designated as a small business set-aside and represents a task order under the Defense Health Agency's existing $5.3 million blanket purchase agreement with Biodiscovery LLC....
- The Defense Health Agency awarded a $169,600 firm fixed-price call under an existing Blanket Purchase Agreement to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, for MYBAITS Mito 384 RXN reagents. This award, issued on February 13, 2025, with an ultimate completion date of February 24, 2025, represents a task order against DHA's $5.3 million single-award BPA with the vendor, which runs through September 27, 2027. The reagents will be delivered to the performance location in Ann...
- This firm fixed-price delivery order, awarded February 6, 2024, represents a $22,910 call against the Defense Health Agency's $5.3 million Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences). The award is for MYBAITS, a proprietary custom DNA reagent manufactured exclusively by Biodiscovery for casework applications. The work will be performed at Biodiscovery's facility in Ann Arbor, Michigan, with an ultimate completion date of September 30, 2024. No...
- The Defense Health Agency awarded a $92,550 firm fixed-price call under its $5.3 million Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on May 24, 2024, with an ultimate completion date of June 18, 2024. The contract, which carries no set-aside designation, calls for the delivery of MYBAITS MITO 384 RXN reagent kits in a quantity of six units. MYBAITS reagents are proprietary custom DNA and RNA-based bait enrichment kits used for targeted genomic...
- The Defense Health Agency awarded a $21,485 firm fixed-price call against its Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on June 27, 2023, with completion expected by September 30, 2023. This task order procures MYBAITS custom reagents, a proprietary molecular biology product manufactured exclusively by Biodiscovery for forensic casework applications. The award was made without a set-aside designation, allowing Biodiscovery to compete openly...
- The Defense Health Agency awarded a $24,985 firm fixed-price Blanket Purchase Agreement (BPA) call to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, for reagent kits. The contract, awarded on January 8, 2024, with an ultimate completion date of September 30, 2024, represents a task order under DHA's larger $5.3 million BPA with Biodiscovery that runs through September 27, 2027. No small business set-aside was utilized for this award. Biodiscovery LLC, a foreign-owned...
- This $107,770 firm fixed price contract was awarded by the Defense Health Agency to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned for-profit manufacturer. The contract is a call under a $5.3 million single-award blanket purchase agreement with the agency to supply custom DNA reagents and MYBAITS reagents through September 2027. The products, including MYBAITS-1-768-B DNA reagents, support the agency's biomedical research and casework by providing specialized...
- W81XWH22A0005Blanket Purchase Agreement
- W81XWH22A0005-HT942726FE010BPA Call
The Defense Health Agency awarded a $185,010 firm fixed-price task order to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on January 29, 2026, for custom target enrichment kits with an ultimate completion date of March 27, 2026. This contract is issued as a call under the agency's existing $5.3 million Blanket Purchase Agreement with Biodiscovery, which enables the DHA to procure the company's proprietary MYBAITS custom DNA reagents and sequencing kits on a firm fixed-price basis. The work will be performed at Biodiscovery's facility in Ann Arbor, Michigan. No small business set-aside designation was applied to this award. Biodiscovery LLC is a foreign-owned manufacturer specializing in advanced molecular biology and synthetic biology solutions, with particular expertise in custom DNA reagents and next-generation sequencing applications. Under the existing BPA vehicle, the company has supplied genomic products supporting the DHA's biomedical research programs, forensic analysis, and diagnostic development initiatives for military service members. This task order represents a continuation of that partnership and reflects the company's role as a key federal supplier of specialized genomic tools and reagents across multiple federal agencies including the National Human Genome Research Institute, CDC, and USDA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $185.0k | 1/28/26 |